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Introduction
Surgical resection is the only curable treatment for duo-
denal ampullar carcinomas (AC) and the resection rate is
higher than those in other biliary carcinomas at this stage.1
Pancreaticoduodenectomy (PD) is usually necessary to ac-
complish complete (R0) resections, which may improve pa-
tient prognosis.1-4 However, on the other hand, physical
stress in patients who undergo PD is relatively high and
postoperative morbidity is still not low because of the soft
architecture of pancreatic tissue.3, 5, 6 Advanced ampullar
carcinoma (AC) may lead to tumor recurrence and related
poor prognosis. To evaluate the present status regarding
surgical treatments for AC at our institute, we examined
our series of PC in 23 patients at a Japanese single cancer
institute and discuss the clinical significance and problems
in the present series.
Method
Patients
We experienced 23 patients undergoing surgical resec-
tion with AC administrated in the Division of Surgical
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Aims: Surgical resection is the only radical treatment option for duodenal ampullar carcinoma (AC) that results in an im-
proved patient prognosis. Method: We examined the demographics, surgical records, and outcome in 23 patients with AC un-
dergoing pancreaticoduodenectomy (PD). Results: Of 23 patients, 17 underwent pylorus preserving PD (PPPD) and 6 under-
went PD, including subtotal stomach-preserving PD in 5. D2 lymphadenectomy was performed in 17 patients and D3
lymphadenectomy was performed in 6. The combined resection of the superior mesenteric vein was performed in 1 patient.
Postoperative cancer recurrence was observed in 32%, and 6 patients died of cancer. The 3-year tumor-free survival rates
were not different between the final stages (p=0.64) and the 5-year cancer-related overall survival rates were not different be-
tween stages either (p=0.28). Tumor size?3cm resulted in significantly poorer survival rate compared to smaller tumors
(p=0.032). Node metastasis at Group 2, and moderately or poorly differentiated adenocarcinoma were significantly associated
with poor survival (p<0.05); however, cancer infiltration at cut-end margin, degree of node dissection and curability were not
associated with overall prognosis. Conclusions: Radical surgical resection showed good patient prognosis; however, new
adjuvant chemotherapy is a promising modality to improve patient survival in AC patients with poor prognostic factors.
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Oncology, Department of Translational Medical Sciences,
Nagasaki University Graduate School of Biomedical Sciences
(NUGSBS) between 1994 and 2008. The study design was
approved by the Human Ethics Review Board of our insti-
tution. Informed consent for data collection was obtained
by each patient during this period. Anesthetic and patient
data were retrieved in the NUGSBS database. Tumor stage
and curability were determined based on the Classification
of Biliary Tract Carcinoma in Japan.7
Operative procedures and follow-up
Pancreaticoduodenectomy or pylorus preserving PD (PPPD)
is a basic surgical option for AC and lymphadenectomy
was performed in Group 2 lymph nodes and lymph nodes
at the para-aortic lesion (station number 16a2 and 16b1).
Basically, PPPD was selected for AC until 2005 and PD
was selected in case that lymph node metastasis was sus-
pected at the peri-pylorus lesion. Since 2006, subtotal stom-
ach-preserving PD (SSPPD) was preferably applied to pre-
vent the postoperative complication of delayed gastric empty.
Extrapancreatic nerve plexus was also resected in the right
side around the supra-mesenteric artery in case of advanced
stage. After PPPD or PD, Child's intestinal reconstruction
with end-to-side anastomosis of pancreatojejunostomy was
routinely selected. In case of tumor involvement to the por-
tal vein or supra-mesenteric vein (SMV), radical operation
was also considered and combined resection of the portal
vein accompanied with an end-to-end anastomosis of the
vessel was performed. Fibrin glue was sprayed to prevent
pancreatic fistula for anastomotic site.
After discharge from the hospital, the patient status, labora-
tory data, and disease recurrence were carefully checked
every 3 months. The minimum follow-up period after op-
eration was 14 months in the present study.
Results
The demographics of AC patients were shown in Table 1.
One patient had a rupture of the marginal artery of the
stomach caused by pancreatic fistula and interventional ra-
diological embolization was performed. Hospital death was
not observed in these patients. Postoperative adjuvant che-
motherapy, which was an oral intake of 600 mg daily of
tegafur-uracil (Taiho Pharmaceutical. Co. Ltd., Tokyo, Japan),
was selected in 3 patients because of highly advanced stage.
Six patients (30%) died of cancer. Figures 1 and 2 show
the cancer-free and overall survival after operation. Mean
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PPPD; pylorus preserving Pancreaticoduodenectomy (PD), SSPPD; subtotal
stomach-preserving PD, SMV; superior mesenteric vein
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cancer-free survival time was 30 months, and 3-year can-
cer-free survival rate was 69%. Mean overall survival time
was 133 months, and 5-year overall survival rate was 66%.
By comparison with tumor stage, 3-year tumor-free sur-
vival and mean cancer-free survival periods were not dif-
ferent between stages (75% in I, 83% in II, 57% in III, and
74 months in I, 105 in II and 62 in III, respectively)
(p=0.64). By comparison with the final stage, 5-year can-
cer-related overall survival and the mean survival period
were not different between stages either (100% in I, 67% in
II, 51% in III, and 93 months in I, 98 in II, 62 in III, respec-
tively) (p=0.28). Table 2 shows the relationship between
overall 5-year survival rate and clinical parameters. Preoperative
CA19-9 level, location of tumor and macroscopic type
were not associated with overall survival. Tumor size over
3cm showed a significantly poorer survival rate compared
to tumors less than 3cm (p<0.05). Postoperative adjuvant
chemotherapy was not related to patient survival. Table 3
shows the relationship between overall 5-year survival rate
and pathological parameters. Node metastasis at Group 2,
and moderately or poorly differentiated adenocarcinoma
was associated with significantly poorer survival. Cancer
infiltration at cut-end margin, degree of node dissection and
curability were not associated with overall prognosis.
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Figure 1. Cumulative cancer-free (a) and overall (b) survival after
hepatectomy.
Figure 2. Comparison between stages of tumor and cumulative
cancer-free (a) and overall (b) survival after hepatectomy.
Table 2. Comparison between overall 5-year survival after resec-
tion and clinical and macroscopic parameters and postoperative
chemotherapy
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Discussion
Surgical exploration is the only curable treatment in pa-
tients with AC and survival is relatively better than in other
biliary tract carcinomas, even in the advanced stage.1-5, 8, 9 As
the techniques and perioperative management for PD,
which is a standard option for AC, have been remarkably
improved, we could actively perform complete tumor re-
sections (R0) during the last 15 years, which improved pa-
tient prognosis.1, 3-6
In our series, the mean age of AC patients tended to be
younger than those in bile duct carcinomas.10 Most patients
had no severe accompanying diseases and their general
condition was good. Preoperative examinations for AC have
not changed dramatically during this 15 years but multi-
detector computed tomography (CT) has been applied since
2001 and preoperative diagnosis of lymph nodes seemed to
be improved.11 At our institute, combinations of imaging
modalities of CT, magnetic resonance image, etc., have been
applied; however, the precise evaluation of cancer exten-
sion or node metastasis is still difficult before operation.12
In the next step, fine needle aspiration or positron emission
tomography must be applied to determine the preoperative
diagnosis for tumor extension or node metastasis.13, 14
Resectability of AC was high and only 1 patient was inoperable
at the time of laparotomy due to peritoneal carcinomatosis,
despite detailed preoperative image examinations in our se-
ries. Radical operation by PD or PPPD was performed in the
present study because of the lack of a candidate for local resec-
tion, which is a standard surgical procedure.3, 4 Furthermore,
most cases underwent D2 lymphadenectomy. Complete
lymphadenectomy at station number 162a and 16b1 are
considered to be necessary because accurate, preoperative
diagnosis is still difficult, as described above.5, 12 Combined
resection of SMV was also aggressively performed to ac-
complish R0 resection in 1 patient. Eventually, problematic
complications such as a pancreatic fistula were observed in
3 patients but 1 had Grade C fistula. Morbidity rate was
low as in previous reports3, 5, 6 and therefore PD or PPPD in
AC could be safely selected. Delayed gastric empty is a
troublesome complication due to anastomosis by PPPD.15
We now use subtotal stomach preserving PD to avoid this
complication.16
Postoperative adjuvant chemotherapy is a recent trend
in patients with advanced biliary tract carcinoma due to de-
velopment of recent chemotherapy using gemcitabine, 5
fluorouracil or S-1 chemotherapy.17-19 In the present series,
we selected S-1 as a promising drug in the future based on
results in gastric carcinomas. These 3 patients had no tumor
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Table 3. Comparison between overall 5-year survival after resec-
tion and pathological parameters
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recurrence during chemotherapy. Lymph node metastasis
was histologically observed in 4 patients although T3 or T4
tumor was observed in 41%. Eventually, stage IV tumor
was not observed in our series. Surgical curability reflects
a good prognosis in AC patients undergoing PD2, 5, 6 and we
accomplished a high rate of curability A (=best grade of
curability). The recurrence rate was relatively lower in
comparison with other biliary tract carcinomas21; however,
tumor recurrence was not rare even in AC in this study.
One patient had a liver metastasis at 10 months after pri-
mary operation; however, no tumor recurrence was ob-
served for over 3 years after hepatic re-resection with ad-
ministration of S-1. Lee et al. also reported the survival
benefit of hepatectomy for liver metastasis (18). We exam-
ined survival results and associated parameters in this
study. The 5-year survival in the present study was similar
to those in previous reports3, 4, 5, 8, 9 and the mean survival pe-
riod was over 10 years.
We compared survival rates between stages, and survival
rates of stage II and III tended to be lower than that of stage
I but no significant difference was observed between stages.
Even patients with advanced stage tumor might have long-
term survival after operation with or without chemotherapy.
By clinico-pathological examinations, serum CA19-9 level,
which is a sensitive marker for malignant behavior,22 did
not correlate with patient survival. In recent unpublished
data, survival rates were increased according to increased
level of CA19-9 in gallbladder carcinomas (not published
yet). By comparison with pathological examination, tumor
size, node metastasis and histological differentiation were
associated parameters with patient prognosis, as well in
previous reports.3, 4, 6, 8, 9, 23-25 Direct invasion to the pancreas
or duodenum, vascular or perineural invasion, number of
node metastasis or minute node metastasis detected by only
immunohistochemistry were also associated with patient
survival.3, 4, 8, 9, 23, 24
Importance of dissected or cut margin was pointed out
and presence of residual tumor must be avoided to improve
survival. Therefore, extended pancreatectomy is still neces-
sary to improve the patient prognoses.3-6 In the present re-
sults, however, these surgical factors were not significantly
associated with prognosis, which might be due to the small
number of subjects at this stage. Further long-term follow-
up with additional subjects is necessary using promising
drugs such as S-1 in high-risk patients with the above pre-
dictive parameters.20
In conclusion, radical pancreaticoduodenectomy was per-
formed in 23 patients with ampullar carcinomas at a single
cancer center over the past 15 years. Radical operation could
be safely performed in most cases. Many patients showed
a good prognosis even in the advanced stage. Tumor size,
node metastasis and histological differentiation were asso-
ciated with improved overall survival but not curability.
The new and effective adjuvant chemotherapy treatments
will be promising to improve patient survival in AC pa-
tients with poor prognostic factors.
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